The Medical Advisor

It is critical to recognize that infection with SARS-CoV-2, the virus that causes COVID-19, progresses through a number of stages and phases. Treatment is therefore highly stage-specific. COVID-19 is a clinical diagnosis; a confirmed antigen or PCR test is not required. Treatment should be initiated immediately after the onset of flu-like symptoms. The multiple therapies and drugs in this protocol have different mechanisms of action and work synergistically during various phases of the disease. The FLCCC I-CARE Early Treatment Protocol The I-Care protocol has been updated several times and below is their latest version ( version 3: September 6, 2022 ). FIRST LINE THERAPIES (In order of priority; not all required) Ivermectin: 0.4 to 0.6 mg/kg – one dose daily for at least 5 days or until symptoms resolve. If symptoms persist longer than 5 days, consult a healthcare provider. See Table 1 for help with calculating correct dose. Due to a possible interaction between quercetin and ivermecti...

As of January 2022, there are more than 80 on-going trials globally on Ivermectin for treatment and prevention of COVID-19 on  covid-nma.com . Source: covid-nma.com Ivermectin is an anti-parasitic medication widely used in low and middle-income countries (LMIC) to treat parasitic worm infections in adults and children. It’s been used for decades for this purpose by over 3.7 billion people, and is considered safe and effective. It has an increasing list of indications due to its antiviral and anti-inflammatory properties, and is included on the WHO’s Model List of Essential Medicines. In April last year, a trial at Melb...

As of February 2021, there are more than 4,300 studies that have been launched to investigate various treatments for COVID-19. You can review the details of these trials on  ClinicalTrials.gov . New ones are being added every day.  Below, we look at the top 10 most tested categories. 1. Vaccine This is the most watched and anticipated category. Technically, vaccine is not considered a treatment but rather a preventive strategy to boost your immune system and reduce the risk of getting COVID-19. As of January 2021, researchers are currently testing  67 vaccines  in clinical trials on humans, and 20 have reached the final stages of testing. The vaccine remains a promising agent for COVID-19 protection, and the published reports of the candidate vaccines showcase some encouraging results. The Bloomberg site tracks the COVID-19 vaccination campaign. Major vaccine candidates: Pfizer/BioNTech COVID-19 mRNA vaccine - This is the first vaccine to receive WHO validation...